Carson Wealth (CWM LLC)
BTAI icon

Carson Wealth (CWM LLC)’s BioXcel Therapeutics BTAI Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio BTAI Stock Details BTAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-53
Closed -$1K – 4842
2024
Q2 		$1K Buy
+53
New +$1.77K ﹤0.01% 4325
2023
Q4 		– Sell
-9
Closed – – 4152
2023
Q3 		$0 Buy
9
+4
+80% +$404 ﹤0.01% 4197
2023
Q2 		$1K Sell
5
-1
-17% -$333 ﹤0.01% 3917
2023
Q1 		$2K Buy
+6
New +$2.56K ﹤0.01% 3620
2022
Q2 		– Sell
-1
Closed – – 3794
2022
Q1 		$0 Sell
1
-1
-50% -$290 ﹤0.01% 3539
2021
Q4 		$1K Buy
+2
New +$858 ﹤0.01% 3255

Other funds holding BTAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Carson Wealth (CWM LLC)'s BTAI Position: Q3 2024 in Review

Carson Wealth (CWM LLC) sold out of BioXcel Therapeutics (BTAI) in Q3 2024, closing a stake of 53 shares — an estimated $1K sold.

Carson Wealth (CWM LLC) first reported a position in BTAI in Q4 2021 and held it in 6 quarters. The position peaked at $2K in Q1 2023. 49 funds tracked by Wall St. Rank hold BTAI as of Q3 2024.

  • Carson Wealth (CWM LLC) reported no remaining BioXcel Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 53 BioXcel Therapeutics shares in Q3 2024, an estimated $1K.
  • Carson Wealth (CWM LLC) first reported a position in BioXcel Therapeutics in Q4 2021 and held it in 6 quarters.
  • Carson Wealth (CWM LLC)'s BioXcel Therapeutics position peaked at $2K in Q1 2023.
  • 49 funds tracked by Wall St. Rank held BioXcel Therapeutics as of Q3 2024.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q3 2024, filed 8 Oct 2024.